EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

137 hedge funds and large institutions have $1.17B invested in Eagle Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+21
Holders Change %
+18.1%
% of All Funds
3.66%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
49
Increased
36
Reduced
33
Closed
28
Calls
$17.5M
Puts
$6.33M
Net Calls
+$11.2M
Net Calls Change
+$7.1M
Name Holding Trade Value Shares
Change
Shares
Change %
KPF
151
K2 Principal Fund
Ontario, Canada
-$640K -16,496 Closed
SSA
152
Schonfeld Strategic Advisors
New York
-$510K -13,135 Closed
Point72 Asset Management
153
Point72 Asset Management
Connecticut
-$440K -11,344 Closed
PG
154
PEAK6 Group
Illinois
-$349K -9,000 Closed
CCI
155
Columbus Circle Investors
-$306K -7,885 Closed
Tudor Investment Corp
156
Tudor Investment Corp
Connecticut
-$272K -7,000 Closed
D.E. Shaw & Co
157
D.E. Shaw & Co
New York
-$213K -5,500 Closed
CG
158
Cutler Group
California
-$110K -2,849 Closed
JG
159
Jefferies Group
New York
-$82K -2,105 Closed
Teacher Retirement System of Texas
160
Teacher Retirement System of Texas
Texas
-$46K -1,198 Closed
MAM
161
Meeder Asset Management
Ohio
-$46K -1,197 Closed
AIM
162
Acrospire Investment Management
Illinois
-$27K -700 Closed
JPMorgan Chase & Co
163
JPMorgan Chase & Co
New York
-$5K -124 Closed
VanEck Associates
164
VanEck Associates
New York
-$3K -89 Closed